You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

challenge dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial (Modified Process Hepatitis B Vaccine)

Completed
Has Results
  • Hepatitis B
  • Modified Process Hepatitis B Vaccine
  • (no location specified)
Aug 19, 2022

Gastroenteritis Norovirus Trial in Cincinnati (Norovirus GII.4 Challenge Pool)

Recruiting
  • Gastroenteritis Norovirus
  • Norovirus GII.4 Challenge Pool
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center - Infectious Disea
Aug 18, 2022

Streptococcus Pneumonia Trial in Liverpool (SPN3 innoculation)

Recruiting
  • Streptococcus Pneumonia
  • SPN3 innoculation
  • Liverpool, United Kingdom
    LSTM
Sep 13, 2022

Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)

Recruiting
  • Immune Response
  • Keyhole-Limpet Hemocyanin
  • +3 more
  • Oxford, United Kingdom
    NIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023

Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)

Recruiting
  • Influenza
  • Influenza RG-A/Texas/71/2017 (H3N2) Challenge
  • Placebo
  • Baltimore, Maryland
  • +1 more
Aug 4, 2022

Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS) Trial in London (Salmonella Typhimurium)

Not yet recruiting
  • Salmonella Infections
  • +7 more
  • Salmonella Typhimurium
  • London, England, United Kingdom
    Imperial College London
May 11, 2023

Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Paris, France
    Hôpital Pitié-Salpêtrière
Oct 24, 2022

Influenza, Human Trial in Leiden (POLB 001, Placebo)

Completed
  • Influenza, Human
  • POLB 001
  • Placebo
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 13, 2023

Influenza A H1N1 Trial in London (Infectious Titre 1, Infectious Titre 2, Infectious Titre 3)

Recruiting
  • Influenza A H1N1
  • Infectious Titre 1
  • +3 more
  • London, United Kingdom
    hVIVO Services Ltd
Oct 6, 2022

Asthma Trial in Tampere (Buventol® Easyhaler® 200 µg/inhalation dmDPI, Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI,

Recruiting
  • Asthma
  • Buventol® Easyhaler® 200 µg/inhalation dmDPI
  • +2 more
  • Tampere, Finland
    Tampere University Hospital
Oct 26, 2022

Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge

Recruiting
  • Dengue
  • Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022

Fragile X Syndrome Trial in Cincinnati (Baclofen, Memantine, Roflumilast)

Recruiting
  • Fragile X Syndrome
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 28, 2022

Influenza Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (A/Mallard/Ohio-99/MM4/1989

Not yet recruiting
  • Influenza Infection
  • A/Mallard/Ohio-99/MM4/1989 H10N7
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)

Not yet recruiting
  • Colitis, Ulcerative
  • Cambridge, United Kingdom
    GSK Investigational Site
Aug 11, 2023

RSV Infection Trial in London (EDP-938 Dose 1, EDP-938 Dose 2, Placebo)

Completed
Has Results
  • RSV Infection
  • EDP-938 Dose 1
  • +4 more
  • London, United Kingdom
    hVIVO Services Limited (hVIVO)
Apr 6, 2022

Campylobacter Infections Trial in Baltimore (LMN-101, Placebo)

Completed
  • Campylobacter Infections
  • LMN-101
  • Placebo
  • Baltimore, Maryland
    Pharmaron
Nov 15, 2022

Bronchial Asthma Trial in Medford (Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Ventolin HFA 90Mcg/Actuation

Not yet recruiting
  • Bronchial Asthma
  • Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)
  • +3 more
  • Medford, Oregon
    Velocity CLinical Research
Nov 23, 2023

Asthma, Cough Variant Asthma Trial in Kingston (high-dose methacholine challenge test, mannitol challenge test)

Completed
  • Asthma
  • Cough Variant Asthma
  • high-dose methacholine challenge test
  • mannitol challenge test
  • Kingston, Ontario, Canada
    Kingston General Hospital
Feb 9, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum)

Recruiting
  • Norovirus Infections
  • VXA-G1.1-NN
  • +2 more
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Dengue Trial in Baltimore, Burlington (JNJ-64281802 (sentinel high dose), JNJ-64281802 (remaining high dose), JNJ-64281802

Recruiting
  • Dengue
  • JNJ-64281802 (sentinel high dose)
  • +6 more
  • Baltimore, Maryland
  • +1 more
May 11, 2022

Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)

Completed
  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Eye Drops, Solution in Single-Dose Container
  • Vienna, Austria
    Vienna Challenge Chamber
Aug 24, 2022

Healthy Trial in Syracuse (Placebo, JNJ-64281802 High dose, JNJ-64281802 Medium dose)

Suspended
  • Healthy
  • Placebo
  • +6 more
  • Syracuse, New York
    SUNY Upstate Medical University
Mar 23, 2022

Mild Persistent Asthma Trial in London (BDP/formoterol, Placebo)

Completed
  • Mild Persistent Asthma
  • London, United Kingdom
    Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Str
Oct 28, 2021

Predictors of Persistent Peanut Allergy at Age 5 Years

Enrolling by invitation
  • Allergy to Peanut
  • Double-blind placebo-controlled peanut challenge
  • (no location specified)
Nov 2, 2022

Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory

Active, not recruiting
Has Results
  • Asthma, Aspirin-induced
    • Bronx, New York
      Montefiore Medical Center
    Jan 13, 2022